Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Iris Bürger"'
Autor:
Krasimira Aleksandrova, Jana Leise, Christoph Priesner, Murat Aktas, Michael Apel, Mario Assenmacher, Iris Bürger, Anne Richter, Pia Altefrohne, Christine Schubert, Astrid Holzinger, Markus Barden, Valerie Bezler, Michael von Bergwelt-Baildon, Peter Borchmann, Lilia Goudeva, Wolfgang Glienke, Lubomir Arseniev, Ruth Esser, Hinrich Abken, Ulrike Koehl
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionPoint-of-care (POC) manufacturing of chimeric antigen receptor (CAR) modified T cell has expanded rapidly over the last decade. In addition to the use of CD19 CAR T cells for hematological diseases, there is a growing interest in targetin
Externí odkaz:
https://doaj.org/article/f6589c518506495e91a9217ebb7da6b4
Autor:
Nicole Cordes, Carolin Kolbe, Dominik Lock, Tatjana Holzer, Deborah Althoff, Daniel Schäfer, Franziska Blaeschke, Bettina Kotter, Sandra Karitzky, Claudia Rossig, Toni Cathomen, Tobias Feuchtinger, Iris Bürger, Mario Assenmacher, Thomas Schaser, Andrew D. Kaiser
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 21, Iss , Pp 42-53 (2021)
Recently, a rare type of relapse was reported upon treating a B cell acute lymphoblastic leukemia (B-ALL) patient with anti-CD19 chimeric antigen receptor (CAR)-T cells caused by unintentional transduction of residual malignant B cells (CAR-B cells).
Externí odkaz:
https://doaj.org/article/c35a2ae8e0aa4f12be416e571f892b51
Autor:
Tatjana Holzer, Stefanie Biedermann, Inga Herfort, Birte Friedrichs, Silke Holtkamp, Linda Hanssens, Mario Assenmacher, Ulf Bethke, Dina Schneider, Stefan Miltenyi, Toon Overstijns, Christoph Schmid, Francis A. Ayuk, Christoph Scheid, Anja Jühling, Udo Holtick, Philipp Gödel, Peter Borchmann, Iris Bürger
Publikováno v:
Blood. 140:4581-4583
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00b8885a44f1f0ccde44080d8b85c3dc
https://doi.org/10.1182/blood-2022-164597
https://doi.org/10.1182/blood-2022-164597
Autor:
Andrew Kaiser, Daniel Schäfer, Iris Bürger, Franziska Blaeschke, Mario Assenmacher, Thomas Schaser, Claudia Rossig, Nicole Cordes, Toni Cathomen, Tobias Feuchtinger, Carolin Kolbe, Sandra Karitzky, Deborah Althoff, Tatjana Holzer, Dominik Lock, Bettina Kotter
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 21, Iss, Pp 42-53 (2021)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy. Methods & Clinical Development
Recently, a rare type of relapse was reported upon treating a B cell acute lymphoblastic leukemia (B-ALL) patient with anti-CD19 chimeric antigen receptor (CAR)-T cells caused by unintentional transduction of residual malignant B cells (CAR-B cells).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78e19ed1d8165db7ab278067b9a1b125
http://www.sciencedirect.com/science/article/pii/S2329050121000280
http://www.sciencedirect.com/science/article/pii/S2329050121000280
Autor:
Nadine Kutsch, Philipp Gödel, Udo Holtick, Anja Lohneis, Vladan Vucinic, Florentine Pia Altefrohne, Christin Schubert, Sandra Karitzky, Linda Hanssens, Mario Assenmacher, Iris Bürger, Murat Aktas, Peter Borchmann
Publikováno v:
Blood. 140:12980-12981
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::021bcd5b65d0360d06942a12ece22c43
https://doi.org/10.1182/blood-2022-168730
https://doi.org/10.1182/blood-2022-168730
Autor:
Peter Borchmann, Peter Vandenberghe, Alvaro Urbano-Ispizua, Corinne Haioun, Francois Lemonnier, Laimonas Griskevicius, Sébastien Maury, Silke Holtkamp, Birte Friedrichs, Gregor Zadoyan, Linda Hanssens, Toon Overstijns, Mario Assenmacher, Ulf Bethke, Iris Bürger, Olaf Reer, Ulrich Jaeger, Marie José Kersten
Publikováno v:
Blood. 140:12784-12785
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::177e6031627daf8d2ea7768b7f226e8d
https://doi.org/10.1182/blood-2022-164650
https://doi.org/10.1182/blood-2022-164650
Autor:
Lilia Goudeva, Fanni Kubaink, Jana Leise, Wolfgang Glienke, Andrew Kaiser, Hinrich Abken, Mike Essl, Ruth Esser, Andreas Hombach, Marion Jurk, Lubomir Arseniev, Murat Aktas, Krasimira Aleksandrova, Ulrike Köhl, Georg Rauser, Iris Bürger, Christoph Priesner, Anette Melk
Publikováno v:
Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie. 46(1)
Clinical studies using autologous CAR T cells have achieved spectacular remissions in refractory CD19+ B cell leukaemia, however some of the patient treatments with CAR T cells failed. Beside the heterogeneity of leukaemia, the distribution and senes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfba8cfc82b49cd300692a8b0c6da3b6
https://pubmed.ncbi.nlm.nih.gov/31244581
https://pubmed.ncbi.nlm.nih.gov/31244581
Autor:
Erik Schneider, Alexandra S. H. Hoch, Iris Bürger, Ulf Bethke, Mayke Busch, Kerstin Zörner, Stefanie Kattenbach
Publikováno v:
Cells and Culture ISBN: 9789048134182
In this study, we demonstrate the effect of MACS® Separation on the diversification pattern of the specific production rate (SPR) of heterogeneous IgG-secreting cell populations. Magnetic separation prior to single-cell subcloning results in an effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b45fbe9f4c133d938c2bb6a013cca071
https://doi.org/10.1007/978-90-481-3419-9_134
https://doi.org/10.1007/978-90-481-3419-9_134
Autor:
Iris Burgers
Publikováno v:
Bulletin KNOB, Pp 40-41 (2021)
Boekbespreking van een boek van Paul Meurs en Isabel van Lent
Externí odkaz:
https://doaj.org/article/879f3c494c78463dacc3e4d4ed04f3d2
Autor:
Andrew Kaiser, Hyatt Balke-Want, Silke Holtkamp, Udo Holtick, Peter Borchmann, Boro Dropulic, Stefan Miltenyi, Marion Jurk, Francis Ayuk, Christof Scheid, Christoph Schmid, Michael Hallek, Dina Schneider, Anja Jühling, Gregor Zadoyan, Toon Overstijns, Philipp Gödel, Liane Preussner, Linda Hanssens, Iris Bürger
Publikováno v:
Web of Science
Background CD19 redirected chimeric antigen receptor (CAR) T-cell therapy has proven efficacy in relapsed or chemotherapy-refractory (r/r) aggressive B-cell non-Hodgkin lymphoma (B-NHL). However, targeting a single B-cell antigen leads to selective p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2b0ec57b51ddc73c077aced05807f7b
https://publons.com/wos-op/publon/54752991/
https://publons.com/wos-op/publon/54752991/